Home Applications 207078 Application 207078
Type NDA
Sponsor ASTRAZENECA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LOKELMA SODIUM ZIRCONIUM CYCLOSILICATE FOR SUSPENSION;ORAL 5GM/PACKET Yes No 002 LOKELMA SODIUM ZIRCONIUM CYCLOSILICATE FOR SUSPENSION;ORAL 10GM/PACKET Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N207078-001 LOKELMA SODIUM ZIRCONIUM CYCLOSILICATE 5GM/PACKET FOR SUSPENSION / ORAL AB RLD 2018-05-18 N207078-002 LOKELMA SODIUM ZIRCONIUM CYCLOSILICATE 10GM/PACKET FOR SUSPENSION / ORAL AB RLD, RS 2018-05-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 27 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N207078-001 10335432 2032-02-10 U-2312 2019-07-25 N207078-001 10398730 2032-02-10 U-2312 2019-10-01 N207078-001 10413569 2032-02-10 Drug substance 2019-10-01 N207078-001 11406662 2032-02-10 Drug substance 2022-09-07 N207078-001 8808750 2032-02-10 U-2312 2018-06-12 N207078-001 9844567 2032-02-10 U-2312 2018-06-12 N207078-001 9861658 2032-02-10 U-2312 2018-06-12 N207078-001 8802152 2032-04-19 Drug substance 2018-06-12 N207078-001 10695365 2033-10-22 Drug substance 2020-07-28 N207078-001 8877255 2033-10-22 Drug substance 2018-06-12 N207078-001 9913860 2033-10-22 U-2312 Drug substance 2019-01-23 N207078-001 10300087 2035-10-14 U-2312 Drug substance 2019-07-25 N207078-001 11738044 2035-10-14 U-2312 2023-09-21 N207078-001 9592253 2035-10-14 U-2312 Drug substance 2018-06-12 N207078-002 10398730 2032-02-10 U-2312 2019-10-01 N207078-002 10413569 2032-02-10 Drug substance 2019-10-01 N207078-002 11406662 2032-02-10 Drug substance 2022-09-07 N207078-002 8808750 2032-02-10 U-2312 2018-06-12 N207078-002 9844567 2032-02-10 U-2312 2018-06-12 N207078-002 9861658 2032-02-10 U-2312 2018-06-12 N207078-002 8802152 2032-04-19 Drug substance 2018-06-12 N207078-002 10695365 2033-10-22 Drug substance 2020-07-28 N207078-002 8877255 2033-10-22 Drug substance 2018-06-12 N207078-002 9913860 2033-10-22 U-2312 Drug substance 2019-01-23 N207078-002 10300087 2035-10-14 U-2312 Drug substance 2019-07-25 N207078-002 11738044 2035-10-14 U-2312 2023-09-21 N207078-002 9592253 2035-10-14 U-2312 Drug substance 2018-06-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL AB RLD 2018-05-18 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL AB RLD, RS 2018-05-18 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL AB RLD 2018-05-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL AB RLD, RS 2018-05-18 c2088c7a36db…2026-09-14 22:38:34 2026-08 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL AB RLD 2018-05-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL AB RLD, RS 2018-05-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL AB RLD 2018-05-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL AB RLD, RS 2018-05-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N207078-001 LOKELMA 5GM/PACKET FOR SUSPENSION / ORAL RLD 2018-05-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N207078-002 LOKELMA 10GM/PACKET FOR SUSPENSION / ORAL RLD, RS 2018-05-18 5d02ea3f76ae…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 29 · 1,134 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N207078-001 10335432 2032-02-10 U-2312 2019-07-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 10398730 2032-02-10 U-2312 2019-10-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 10413569 2032-02-10 Drug substance 2019-10-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 11406662 2032-02-10 Drug substance 2022-09-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 8808750 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 9844567 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 9861658 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 8802152 2032-04-19 Drug substance 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 10695365 2033-10-22 Drug substance 2020-07-28 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 8877255 2033-10-22 Drug substance 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 9913860 2033-10-22 U-2312 Drug substance 2019-01-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 10300087 2035-10-14 U-2312 Drug substance 2019-07-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 11738044 2035-10-14 U-2312 2023-09-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-001 9592253 2035-10-14 U-2312 Drug substance 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 10398730 2032-02-10 U-2312 2019-10-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 10413569 2032-02-10 Drug substance 2019-10-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 11406662 2032-02-10 Drug substance 2022-09-07 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 8808750 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 9844567 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 9861658 2032-02-10 U-2312 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 8802152 2032-04-19 Drug substance 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 10695365 2033-10-22 Drug substance 2020-07-28 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 8877255 2033-10-22 Drug substance 2018-06-12 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 9913860 2033-10-22 U-2312 Drug substance 2019-01-23 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 10300087 2035-10-14 U-2312 Drug substance 2019-07-25 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 11738044 2035-10-14 U-2312 2023-09-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N207078-002 9592253 2035-10-14 U-2312 Drug substance 2018-06-12 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N207078-001 10335432 2032-02-10 U-2312 2019-07-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 10398730 2032-02-10 U-2312 2019-10-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 10413569 2032-02-10 Drug substance 2019-10-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 11406662 2032-02-10 Drug substance 2022-09-07 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 8808750 2032-02-10 U-2312 2018-06-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 9844567 2032-02-10 U-2312 2018-06-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 9861658 2032-02-10 U-2312 2018-06-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 8802152 2032-04-19 Drug substance 2018-06-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 10695365 2033-10-22 Drug substance 2020-07-28 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 8877255 2033-10-22 Drug substance 2018-06-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 9913860 2033-10-22 U-2312 Drug substance 2019-01-23 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 10300087 2035-10-14 U-2312 Drug substance 2019-07-25 c2088c7a36db…2026-10-15 13:18:30 2026-09 N207078-001 11738044 2035-10-14 U-2312 2023-09-21 c2088c7a36db…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 88 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 16 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1105 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current 0310-1110 LOKELMA sodium zirconium cyclosilicate AstraZeneca Pharmaceuticals LP NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 77461 SUPPL 2024-02-12 77443 SUPPL 2024-02-09 72228 SUPPL 2022-10-03 72208 SUPPL 2022-10-03 69042 SUPPL 2021-10-21 69032 SUPPL 2021-10-20 62699 SUPPL 2020-04-28 62681 SUPPL 2020-04-27 54477 ORIG 2018-06-08 54271 ORIG 2018-05-21 54257 ORIG 2018-05-18